liquiritigenin has been researched along with Age-Related Memory Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jang, CG; Ko, YH; Kwon, SH; Lee, SY | 1 |
Fu, JY; Liu, RT; Lu, QJ; Zou, LB | 1 |
Fu, JY; Liu, RT; Lu, QJ; Tang, JT; Zou, LB | 1 |
3 other study(ies) available for liquiritigenin and Age-Related Memory Disorders
Article | Year |
---|---|
Liquiritigenin ameliorates memory and cognitive impairment through cholinergic and BDNF pathways in the mouse hippocampus.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Disease Models, Animal; Flavanones; Hippocampus; Male; Memory Disorders; Mice, Inbred Strains; Neuroprotective Agents; Scopolamine | 2017 |
Effects of liquiritigenin treatment on the learning and memory deficits induced by amyloid beta-peptide (25-35) in rats.
Topics: Amyloid beta-Peptides; Animals; Brain; Cell Count; Estrogen Receptor beta; Female; Flavanones; Learning Disabilities; Male; Memory Disorders; Neurons; Neuropsychological Tests; Nootropic Agents; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Receptor, Notch2; RNA, Messenger; Selective Estrogen Receptor Modulators | 2010 |
Liquiritigenin attenuates the learning and memory deficits in an amyloid protein precursor transgenic mouse model and the underlying mechanisms.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Astrocytes; Avoidance Learning; CA1 Region, Hippocampal; Disease Models, Animal; Female; Flavanones; Glial Fibrillary Acidic Protein; Gliosis; Learning; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Nootropic Agents; Receptor, Notch2 | 2011 |